ITEMS IN AFP WITH KEYWORD:
Photo Quiz presents readers with a clinical challenge based on a photograph or other image.
The American Heart Association (AHA) has published a scientific statement on drug therapy for the treatment of high-risk lipid abnormalities in children and adolescents.
Hypertriglyceridemia is associated with an increased risk of cardiovascular events and acute pancreatitis. Along with lowering low-density lipoprotein cholesterol levels and raising high-density lipoprotein cholesterol levels, lowering triglyceride levels in high-risk patients (e.g., those with card...
Apr 1, 2006 Issue
CDC Reports on Trends in Cholesterol Screening and Awareness [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has published a report on the prevalence of cholesterol screening and awareness using data from the Behavioral Risk Factor Surveillance System.
Low doses of ezetimibe/simvastatin provide greater improvements in lipid profile than simvastatin or atorvastatin monotherapy. Ezetimibe/simvastatin may be useful in patients who are unable to tolerate high-dose statin therapy. Combination ezetimibe-simvastatin is less expensive than adding ezetimib...
Colesevelam lowers LDL cholesterol levels a small amount (7 to 16 percent) when used alone and provides additional cholesterol lowering when added to statin therapy. It has a slightly beneficial effect on HDL cholesterol levels, has no effect on triglyceride levels, and is well tolerated.
Cardiovascular disease and its subset coronary heart disease are leading causes of morbidity and mortality in the United States and worldwide. In general, higher levels of low-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease, myocardial infarction, and ...
Oct 15, 2004 Issue
NCEP Issues Interim Guidelines on Management of Cholesterol [Practice Guidelines]
The National Cholesterol Education Program (NCEP) recently issued interim guidelines as an addendum to the 2002 Adult Treatment Panel III (ATP III) guidelines regarding the management of cholesterol.
The constellation of dyslipidemia (hypertriglyceridemia and low levels of high-density lipoprotein cholesterol), elevated blood pressure, impaired glucose tolerance, and central obesity is identified now as metabolic syndrome, also called syndrome X. Soon, metabolic syndrome will overtake cigarette ...
Ezetimibe is safe and effective for lowering LDL cholesterol and triglyceride levels, but has not been shown to affect patient-oriented outcomes. It can be used as monotherapy or in combination with a low-dose statin, although the combination is more expensive than the maximum dose of the statin.